In This Section      
 

Pharmacy Residency Program: Investigational Drugs and Research

Program Type: ASHP Accreditation Candidate

ASHP Match Number:  254347

Purpose: This specialty residency training program in Investigational Drug Service is an organized, directed postgraduate program to develop the knowledge, skills, and abilities required to support clinical drug research. The residency is designed to develop expert skills in a variety of settings that provide care for patients enrolled in clinical trials. The program was created in order to produce qualified residents capable of performing in an advanced practice care role.

Program Overview: Graduates of the program will have competencies in the provision of care for research participants, the regulatory requirements that govern clinical research, and pharmacy operations required to support the evolving and complex clinical research enterprise. Participants will be expected to be a leader capable of managing the care of research participants, collaborating with the health care team to provide safe and effective care to research participants, understanding institutional operations for the conduct of research, and advancing practice for this patient population.  

 

Training Experience:

  • Collaboration with the health care team to provide safe and effective patient care
  • Understanding of the drug approval process and the implications of each component on organizational operations and role of key stakeholders
  • Management of the medication –use process for drugs used in clinical trials
  • Understanding of  institutional, federal and state regulations that govern research
  • Strategies in the prevention of medication errors and adverse events
  • Develop skills in financial management and budgeting of services to support clinical trials
  • Experience with the external agencies, organizations and sponsors that impact the conduct of research

 

Residency Rotation:

Core rotations

  • Investigational Drug Service
  • Investigational Drug Service–Oncology
  • Clinical Research Operations
  • Human Research Protections and IRB Review
  • Drug Development–Clinical Pharmacology (2)
  • Clinical Care with Research Patients (ex: Hematologic Malignancies or Pediatric Oncology)
  • Investigational Drug Service Leadership
  • Oncology Medication Use Safety (Longitudinal)
  • Oncology Clinical Decision Support

Elective rotations

  • NIH: National Cancer Institute, Pharmaceutical Management Branch

Benefits: http://www.hopkinsmedicine.org/pharmacy/residents/benefits/index.html

Staffing: http://www.hopkinsmedicine.org/pharmacy/residents/about/staffing.html

On-Call: http://www.hopkinsmedicine.org/pharmacy/residents/about/on-call.html

 

Application Information:

  • All applications will be accepted through PhORCAS.
  • Pre-requisites for the Investigational Drugs and Research PGY1/PGY2 program:
    • Doctor of Pharmacy degree from an ACPE accredited school or college.
    • Minimum 3.0 GPA on a 4.0 scale.
  • Link to the application information: http://www.hopkinsmedicine.org/pharmacy/residents/application/

Special Requirements for Application: Eligibility for licensure in Maryland. Application material should include a curriculum vitae documenting: (a) education, (b) work experience, (c) rotations, (d) community service, (e) association involvement, (f) leadership, (g) awards/honors, (h) presentations and publications, (i) letter of intent, (j) three references and your (k) College of Pharmacy transcript. Participation in the ASHP Matching program as a PGY-1 candidate. Participation in Personnel Placement Service at the Midyear Clinical Meeting is recommended.

 

 

Janet Mighty, B.S. Pharm, M.B.A.

Janet Mighty, B.S. Pharm, M.B.A.

Director, Investigational Drug Service
B.S. Pharmacy, University of Maryland
Masters in Business Administration, Loyola College, Baltimore, MD

Contact Information

Location: The Johns Hopkins Hospital
600 North Wolfe St./Carnegie 180
Baltimore, MD 21287-6180

Phone (Office): 410-955-6337
Email: jmighty1@jhmi.edu